IPG Photonics to acquire Lumibird Medical for €300M to expand into ophthalmology lasers

Filed July 17, 2026 · Period ending July 16, 2026 · ~2 min read

Key Changes

• high

  IPG entered a binding agreement to acquire Lumibird Medical for €300M cash (~$349M) plus up to €50M earnout tied to 2026-2027 performance, funded from existing cash; closing expected Q4 2026 pending French labor consultation and regulatory approvals.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
• high

  Acquisition adds ~$1B addressable market in ophthalmology, combining with IPG's existing $74M medical business (urology/dermatology) to create a scaled medical laser platform representing ~26% of pro forma revenue, up from 16%.

  Exhibit 99.2 view on EDGAR →
• high

  Lumibird Medical generated €112.2M revenue with 21.5% EBITDA margin in FY2025; IPG expects the acquisition to be accretive to gross margin, EBITDA, and adjusted EPS by adding a high-margin business.

  Exhibit 99.1 view on EDGAR →